[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |
Advanced search

Asia-Pacific Sickle Cell Disease Drug Market Report 2018

March 2018 | 116 pages | ID: A6A647AD024QEN
QYResearch

US$ 4,000.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
In this report, the Asia-Pacific Sickle Cell Disease Drug market is valued at USD XX million in 2017 and is expected to reach USD XX million by the end of 2025, growing at a CAGR of XX% between 2017 and 2025.

Geographically, this report split Asia-Pacific into several key Regions, with sales (K Pcs), revenue (Million USD), market share and growth rate of Sickle Cell Disease Drug for these regions, from 2013 to 2025 (forecast), including
  • China
  • Japan
  • South Korea
  • Taiwan
  • India
  • Southeast Asia
  • Australia
Asia-Pacific Sickle Cell Disease Drug market competition by top manufacturers/players, with Sickle Cell Disease Drug sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including
  • Acceleron Pharma Inc
  • Addmedica SAS
  • Angiocrine Bioscience Inc
  • Annexin Pharmaceuticals AB
  • ArQule Inc
  • Bio Products Laboratory Ltd
  • Bioverativ Inc
  • bluebird bio Inc
  • Bristol-Myers Squibb Co
  • Calimmune Inc
  • CRISPR Therapeutics
  • CSL Ltd
  • Daiichi Sankyo Co Ltd
  • Editas Medicine Inc
  • Errant Gene Therapeutics LLC
  • Gamida Cell Ltd
  • Genethon SA
  • Gilead Sciences Inc
  • Global Blood Therapeutics Inc
On the basis of product, this report displays the sales volum, revenue, product price, market share and growth rate of each type, primarily split into
  • ARQ-092
  • BIVV-003
  • CAL-H
  • CTX-001
  • DRX-194
  • Others
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
  • Hospital
  • Clinic
  • Others
If you have any special requirements, please let us know and we will offer you the report as you want.
Asia-Pacific Sickle Cell Disease Drug Market Report 2018

1 SICKLE CELL DISEASE DRUG OVERVIEW

1.1 Product Overview and Scope of Sickle Cell Disease Drug
1.2 Classification of Sickle Cell Disease Drug by Product Category
  1.2.1 Asia-Pacific Sickle Cell Disease Drug Market Size (Sales) Comparison by Types (2013-2025)
  1.2.2 Asia-Pacific Sickle Cell Disease Drug Market Size (Sales) Market Share by Type (Product Category) in 2017
  1.2.3 ARQ-092
  1.2.4 BIVV-003
  1.2.5 CAL-H
  1.2.6 CTX-001
  1.2.7 DRX-194
  1.2.8 Others
1.3 Asia-Pacific Sickle Cell Disease Drug Market by Application/End Users
  1.3.1 Asia-Pacific Sickle Cell Disease Drug Sales (Volume) and Market Share Comparison by Applications (2013-2025)
  1.3.2 Hospital
  1.3.3 Clinic
  1.3.4 Others
1.4 Asia-Pacific Sickle Cell Disease Drug Market by Region
  1.4.1 Asia-Pacific Sickle Cell Disease Drug Market Size (Value) Comparison by Region (2013-2025)
  1.4.2 China Status and Prospect (2013-2025)
  1.4.3 Japan Status and Prospect (2013-2025)
  1.4.4 South Korea Status and Prospect (2013-2025)
  1.4.5 Taiwan Status and Prospect (2013-2025)
  1.4.6 India Status and Prospect (2013-2025)
  1.4.7 Southeast Asia Status and Prospect (2013-2025)
  1.4.8 Australia Status and Prospect (2013-2025)
1.5 Asia-Pacific Market Size (Value and Volume) of Sickle Cell Disease Drug (2013-2025)
  1.5.1 Asia-Pacific Sickle Cell Disease Drug Sales and Growth Rate (2013-2025)
  1.5.2 Asia-Pacific Sickle Cell Disease Drug Revenue and Growth Rate (2013-2025)

2 ASIA-PACIFIC SICKLE CELL DISEASE DRUG COMPETITION BY PLAYERS/SUPPLIERS, REGION, TYPE AND APPLICATION

2.1 Asia-Pacific Sickle Cell Disease Drug Market Competition by Players/Suppliers
  2.1.1 Asia-Pacific Sickle Cell Disease Drug Sales Volume and Market Share of Key Players/Suppliers (2013-2018)
  2.1.2 Asia-Pacific Sickle Cell Disease Drug Revenue and Share by Players/Suppliers (2013-2018)
2.2 Asia-Pacific Sickle Cell Disease Drug (Volume and Value) by Type
  2.2.1 Asia-Pacific Sickle Cell Disease Drug Sales and Market Share by Type (2013-2018)
  2.2.2 Asia-Pacific Sickle Cell Disease Drug Revenue and Market Share by Type (2013-2018)
2.3 Asia-Pacific Sickle Cell Disease Drug (Volume) by Application
2.4 Asia-Pacific Sickle Cell Disease Drug (Volume and Value) by Region
  2.4.1 Asia-Pacific Sickle Cell Disease Drug Sales and Market Share by Region (2013-2018)
  2.4.2 Asia-Pacific Sickle Cell Disease Drug Revenue and Market Share by Region (2013-2018)

3 CHINA SICKLE CELL DISEASE DRUG (VOLUME, VALUE AND SALES PRICE)

3.1 China Sickle Cell Disease Drug Sales and Value (2013-2018)
  3.1.1 China Sickle Cell Disease Drug Sales Volume and Growth Rate (2013-2018)
  3.1.2 China Sickle Cell Disease Drug Revenue and Growth Rate (2013-2018)
  3.1.3 China Sickle Cell Disease Drug Sales Price Trend (2013-2018)
3.2 China Sickle Cell Disease Drug Sales Volume and Market Share by Type
3.3 China Sickle Cell Disease Drug Sales Volume and Market Share by Application

4 JAPAN SICKLE CELL DISEASE DRUG (VOLUME, VALUE AND SALES PRICE)

4.1 Japan Sickle Cell Disease Drug Sales and Value (2013-2018)
  4.1.1 Japan Sickle Cell Disease Drug Sales Volume and Growth Rate (2013-2018)
  4.1.2 Japan Sickle Cell Disease Drug Revenue and Growth Rate (2013-2018)
  4.1.3 Japan Sickle Cell Disease Drug Sales Price Trend (2013-2018)
4.2 Japan Sickle Cell Disease Drug Sales Volume and Market Share by Type
4.3 Japan Sickle Cell Disease Drug Sales Volume and Market Share by Application

5 SOUTH KOREA SICKLE CELL DISEASE DRUG (VOLUME, VALUE AND SALES PRICE)

5.1 South Korea Sickle Cell Disease Drug Sales and Value (2013-2018)
  5.1.1 South Korea Sickle Cell Disease Drug Sales Volume and Growth Rate (2013-2018)
  5.1.2 South Korea Sickle Cell Disease Drug Revenue and Growth Rate (2013-2018)
  5.1.3 South Korea Sickle Cell Disease Drug Sales Price Trend (2013-2018)
5.2 South Korea Sickle Cell Disease Drug Sales Volume and Market Share by Type
5.3 South Korea Sickle Cell Disease Drug Sales Volume and Market Share by Application

6 TAIWAN SICKLE CELL DISEASE DRUG (VOLUME, VALUE AND SALES PRICE)

6.1 Taiwan Sickle Cell Disease Drug Sales and Value (2013-2018)
  6.1.1 Taiwan Sickle Cell Disease Drug Sales Volume and Growth Rate (2013-2018)
  6.1.2 Taiwan Sickle Cell Disease Drug Revenue and Growth Rate (2013-2018)
  6.1.3 Taiwan Sickle Cell Disease Drug Sales Price Trend (2013-2018)
6.2 Taiwan Sickle Cell Disease Drug Sales Volume and Market Share by Type
6.3 Taiwan Sickle Cell Disease Drug Sales Volume and Market Share by Application

7 INDIA SICKLE CELL DISEASE DRUG (VOLUME, VALUE AND SALES PRICE)

7.1 India Sickle Cell Disease Drug Sales and Value (2013-2018)
  7.1.1 India Sickle Cell Disease Drug Sales Volume and Growth Rate (2013-2018)
  7.1.2 India Sickle Cell Disease Drug Revenue and Growth Rate (2013-2018)
  7.1.3 India Sickle Cell Disease Drug Sales Price Trend (2013-2018)
7.2 India Sickle Cell Disease Drug Sales Volume and Market Share by Type
7.3 India Sickle Cell Disease Drug Sales Volume and Market Share by Application

8 SOUTHEAST ASIA SICKLE CELL DISEASE DRUG (VOLUME, VALUE AND SALES PRICE)

8.1 Southeast Asia Sickle Cell Disease Drug Sales and Value (2013-2018)
  8.1.1 Southeast Asia Sickle Cell Disease Drug Sales Volume and Growth Rate (2013-2018)
  8.1.2 Southeast Asia Sickle Cell Disease Drug Revenue and Growth Rate (2013-2018)
  8.1.3 Southeast Asia Sickle Cell Disease Drug Sales Price Trend (2013-2018)
8.2 Southeast Asia Sickle Cell Disease Drug Sales Volume and Market Share by Type
8.3 Southeast Asia Sickle Cell Disease Drug Sales Volume and Market Share by Application

9 AUSTRALIA SICKLE CELL DISEASE DRUG (VOLUME, VALUE AND SALES PRICE)

9.1 Australia Sickle Cell Disease Drug Sales and Value (2013-2018)
  9.1.1 Australia Sickle Cell Disease Drug Sales Volume and Growth Rate (2013-2018)
  9.1.2 Australia Sickle Cell Disease Drug Revenue and Growth Rate (2013-2018)
  9.1.3 Australia Sickle Cell Disease Drug Sales Price Trend (2013-2018)
9.2 Australia Sickle Cell Disease Drug Sales Volume and Market Share by Type
9.3 Australia Sickle Cell Disease Drug Sales Volume and Market Share by Application

10 ASIA-PACIFIC SICKLE CELL DISEASE DRUG PLAYERS/SUPPLIERS PROFILES AND SALES DATA

10.1 Acceleron Pharma Inc
  10.1.1 Company Basic Information, Manufacturing Base and Competitors
  10.1.2 Sickle Cell Disease Drug Product Category, Application and Specification
    10.1.2.1 Product A
    10.1.2.2 Product B
  10.1.3 Acceleron Pharma Inc Sickle Cell Disease Drug Sales, Revenue, Price and Gross Margin (2013-2018)
  10.1.4 Main Business/Business Overview
10.2 Addmedica SAS
  10.2.1 Company Basic Information, Manufacturing Base and Competitors
  10.2.2 Sickle Cell Disease Drug Product Category, Application and Specification
    10.2.2.1 Product A
    10.2.2.2 Product B
  10.2.3 Addmedica SAS Sickle Cell Disease Drug Sales, Revenue, Price and Gross Margin (2013-2018)
  10.2.4 Main Business/Business Overview
10.3 Angiocrine Bioscience Inc
  10.3.1 Company Basic Information, Manufacturing Base and Competitors
  10.3.2 Sickle Cell Disease Drug Product Category, Application and Specification
    10.3.2.1 Product A
    10.3.2.2 Product B
  10.3.3 Angiocrine Bioscience Inc Sickle Cell Disease Drug Sales, Revenue, Price and Gross Margin (2013-2018)
  10.3.4 Main Business/Business Overview
10.4 Annexin Pharmaceuticals AB
  10.4.1 Company Basic Information, Manufacturing Base and Competitors
  10.4.2 Sickle Cell Disease Drug Product Category, Application and Specification
    10.4.2.1 Product A
    10.4.2.2 Product B
  10.4.3 Annexin Pharmaceuticals AB Sickle Cell Disease Drug Sales, Revenue, Price and Gross Margin (2013-2018)
  10.4.4 Main Business/Business Overview
10.5 ArQule Inc
  10.5.1 Company Basic Information, Manufacturing Base and Competitors
  10.5.2 Sickle Cell Disease Drug Product Category, Application and Specification
    10.5.2.1 Product A
    10.5.2.2 Product B
  10.5.3 ArQule Inc Sickle Cell Disease Drug Sales, Revenue, Price and Gross Margin (2013-2018)
  10.5.4 Main Business/Business Overview
10.6 Bio Products Laboratory Ltd
  10.6.1 Company Basic Information, Manufacturing Base and Competitors
  10.6.2 Sickle Cell Disease Drug Product Category, Application and Specification
    10.6.2.1 Product A
    10.6.2.2 Product B
  10.6.3 Bio Products Laboratory Ltd Sickle Cell Disease Drug Sales, Revenue, Price and Gross Margin (2013-2018)
  10.6.4 Main Business/Business Overview
10.7 Bioverativ Inc
  10.7.1 Company Basic Information, Manufacturing Base and Competitors
  10.7.2 Sickle Cell Disease Drug Product Category, Application and Specification
    10.7.2.1 Product A
    10.7.2.2 Product B
  10.7.3 Bioverativ Inc Sickle Cell Disease Drug Sales, Revenue, Price and Gross Margin (2013-2018)
  10.7.4 Main Business/Business Overview
10.8 bluebird bio Inc
  10.8.1 Company Basic Information, Manufacturing Base and Competitors
  10.8.2 Sickle Cell Disease Drug Product Category, Application and Specification
    10.8.2.1 Product A
    10.8.2.2 Product B
  10.8.3 bluebird bio Inc Sickle Cell Disease Drug Sales, Revenue, Price and Gross Margin (2013-2018)
  10.8.4 Main Business/Business Overview
10.9 Bristol-Myers Squibb Co
  10.9.1 Company Basic Information, Manufacturing Base and Competitors
  10.9.2 Sickle Cell Disease Drug Product Category, Application and Specification
    10.9.2.1 Product A
    10.9.2.2 Product B
  10.9.3 Bristol-Myers Squibb Co Sickle Cell Disease Drug Sales, Revenue, Price and Gross Margin (2013-2018)
  10.9.4 Main Business/Business Overview
10.10 Calimmune Inc
  10.10.1 Company Basic Information, Manufacturing Base and Competitors
  10.10.2 Sickle Cell Disease Drug Product Category, Application and Specification
    10.10.2.1 Product A
    10.10.2.2 Product B
  10.10.3 Calimmune Inc Sickle Cell Disease Drug Sales, Revenue, Price and Gross Margin (2013-2018)
  10.10.4 Main Business/Business Overview
10.11 CRISPR Therapeutics
10.12 CSL Ltd
10.13 Daiichi Sankyo Co Ltd
10.14 Editas Medicine Inc
10.15 Errant Gene Therapeutics LLC
10.16 Gamida Cell Ltd
10.17 Genethon SA
10.18 Gilead Sciences Inc
10.19 Global Blood Therapeutics Inc

11 SICKLE CELL DISEASE DRUG MANUFACTURING COST ANALYSIS

11.1 Sickle Cell Disease Drug Key Raw Materials Analysis
  11.1.1 Key Raw Materials
  11.1.2 Price Trend of Key Raw Materials
  11.1.3 Key Suppliers of Raw Materials
  11.1.4 Market Concentration Rate of Raw Materials
11.2 Proportion of Manufacturing Cost Structure
  11.2.1 Raw Materials
  11.2.2 Labor Cost
  11.2.3 Manufacturing Expenses
11.3 Manufacturing Process Analysis of Sickle Cell Disease Drug

12 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

12.1 Sickle Cell Disease Drug Industrial Chain Analysis
12.2 Upstream Raw Materials Sourcing
12.3 Raw Materials Sources of Sickle Cell Disease Drug Major Manufacturers in 2017
12.4 Downstream Buyers

13 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

13.1 Marketing Channel
  13.1.1 Direct Marketing
  13.1.2 Indirect Marketing
  13.1.3 Marketing Channel Development Trend
13.2 Market Positioning
  13.2.1 Pricing Strategy
  13.2.2 Brand Strategy
  13.2.3 Target Client
13.3 Distributors/Traders List

14 MARKET EFFECT FACTORS ANALYSIS

14.1 Technology Progress/Risk
  14.1.1 Substitutes Threat
  14.1.2 Technology Progress in Related Industry
14.2 Consumer Needs/Customer Preference Change
14.3 Economic/Political Environmental Change

15 ASIA-PACIFIC SICKLE CELL DISEASE DRUG MARKET FORECAST (2018-2025)

15.1 Asia-Pacific Sickle Cell Disease Drug Sales Volume, Revenue and Price Forecast (2018-2025)
  15.1.1 Asia-Pacific Sickle Cell Disease Drug Sales Volume and Growth Rate Forecast (2018-2025)
  15.1.2 Asia-Pacific Sickle Cell Disease Drug Revenue and Growth Rate Forecast (2018-2025)
  15.1.3 Asia-Pacific Sickle Cell Disease Drug Price and Trend Forecast (2018-2025)
15.2 Asia-Pacific Sickle Cell Disease Drug Sales Volume, Revenue and Growth Rate Forecast by Region (2018-2025)
  15.2.1 Asia-Pacific Sickle Cell Disease Drug Sales Volume and Growth Rate Forecast by Region (2018-2025)
  15.2.2 Asia-Pacific Sickle Cell Disease Drug Revenue and Growth Rate Forecast by Region (2018-2025)
  15.2.3 China Sickle Cell Disease Drug Sales, Revenue and Growth Rate Forecast (2018-2025)
  15.2.4 Japan Sickle Cell Disease Drug Sales, Revenue and Growth Rate Forecast (2018-2025)
  15.2.5 South Korea Sickle Cell Disease Drug Sales, Revenue and Growth Rate Forecast (2018-2025)
  15.2.6 Taiwan Sickle Cell Disease Drug Sales, Revenue and Growth Rate Forecast (2018-2025)
  15.2.7 India Sickle Cell Disease Drug Sales, Revenue and Growth Rate Forecast (2018-2025)
  15.2.8 Southeast Asia Sickle Cell Disease Drug Sales, Revenue and Growth Rate Forecast (2018-2025)
  15.2.9 Australia Sickle Cell Disease Drug Sales, Revenue and Growth Rate Forecast (2018-2025)
15.3 Asia-Pacific Sickle Cell Disease Drug Sales, Revenue and Price Forecast by Type (2018-2025)
  15.3.1 Asia-Pacific Sickle Cell Disease Drug Sales Forecast by Type (2018-2025)
  15.3.2 Asia-Pacific Sickle Cell Disease Drug Revenue Forecast by Type (2018-2025)
  15.3.3 Asia-Pacific Sickle Cell Disease Drug Price Forecast by Type (2018-2025)
15.4 Asia-Pacific Sickle Cell Disease Drug Sales Forecast by Application (2018-2025)

16 RESEARCH FINDINGS AND CONCLUSION

17 APPENDIX

17.1 Methodology/Research Approach
  17.1.1 Research Programs/Design
  17.1.2 Market Size Estimation
  17.1.3 Market Breakdown and Data Triangulation
17.2 Data Source
  17.2.1 Secondary Sources
  17.2.2 Primary Sources
17.3 Disclaimer

The report requires updating with new data and is sent in 2-3 business days after order is placed.


LIST OF TABLES AND FIGURES

Figure Product Picture of Sickle Cell Disease Drug
Figure Asia-Pacific Sickle Cell Disease Drug Sales Volume (K Pcs) by Type (2013-2025)
Figure Asia-Pacific Sickle Cell Disease Drug Sales Volume Market Share by Type (Product Category) in 2017
Figure ARQ-092 Product Picture
Figure BIVV-003 Product Picture
Figure CAL-H Product Picture
Figure CTX-001 Product Picture
Figure DRX-194 Product Picture
Figure Others Product Picture
Figure Asia-Pacific Sickle Cell Disease Drug Sales (K Pcs) by Application (2013-2025)
Figure Asia-Pacific Sales Market Share of Sickle Cell Disease Drug by Application in 2017
Figure Hospital Examples
Table Key Downstream Customer in Hospital
Figure Clinic Examples
Table Key Downstream Customer in Clinic
Figure Others Examples
Table Key Downstream Customer in Others
Figure Asia-Pacific Sickle Cell Disease Drug Market Size (Million USD) by Region (2013-2025)
Figure China Sickle Cell Disease Drug Revenue (Million USD) and Growth Rate (2013-2025)
Figure Japan Sickle Cell Disease Drug Revenue (Million USD) and Growth Rate (2013-2025)
Figure South Korea Sickle Cell Disease Drug Revenue (Million USD) and Growth Rate (2013-2025)
Figure Taiwan Sickle Cell Disease Drug Revenue (Million USD) and Growth Rate (2013-2025)
Figure India Sickle Cell Disease Drug Revenue (Million USD) and Growth Rate (2013-2025)
Figure Southeast Asia Sickle Cell Disease Drug Revenue (Million USD) and Growth Rate (2013-2025)
Figure Australia Sickle Cell Disease Drug Revenue (Million USD) and Growth Rate (2013-2025)
Figure Asia-Pacific Sickle Cell Disease Drug Sales Volume (K Pcs) and Growth Rate (2013-2025)
Figure Asia-Pacific Sickle Cell Disease Drug Revenue (Million USD) and Growth Rate (2013-2025)
Figure Asia-Pacific Sickle Cell Disease Drug Market Major Players Product Sales Volume (K Pcs)(2013-2018)
Table Asia-Pacific Sickle Cell Disease Drug Sales (K Pcs) of Key Players/Suppliers (2013-2018)
Table Asia-Pacific Sickle Cell Disease Drug Sales Share by Players/Suppliers (2013-2018)
Figure 2017 Asia-Pacific Sickle Cell Disease Drug Sales Share by Players/Suppliers
Figure 2017 Asia-Pacific Sickle Cell Disease Drug Sales Share by Players/Suppliers
Figure Asia-Pacific Sickle Cell Disease Drug Market Major Players Product Revenue (Million USD) 2013-2018
Table Asia-Pacific Sickle Cell Disease Drug Revenue (Million USD) by Players/Suppliers (2013-2018)
Table Asia-Pacific Sickle Cell Disease Drug Revenue Share by Players/Suppliers (2013-2018)
Figure 2017 Asia-Pacific Sickle Cell Disease Drug Revenue Share by Players
Figure 2017 Asia-Pacific Sickle Cell Disease Drug Revenue Share by Players
Table Asia-Pacific Sickle Cell Disease Drug Sales and Market Share by Type (2013-2018)
Table Asia-Pacific Sickle Cell Disease Drug Sales Share by Type (2013-2018)
Figure Sales Market Share of Sickle Cell Disease Drug by Type (2013-2018)
Figure Asia-Pacific Sickle Cell Disease Drug Sales Growth Rate by Type (2013-2018)
Table Asia-Pacific Sickle Cell Disease Drug Revenue (Million USD) and Market Share by Type (2013-2018)
Table Asia-Pacific Sickle Cell Disease Drug Revenue Share by Type (2013-2018)
Figure Revenue Market Share of Sickle Cell Disease Drug by Type (2013-2018)
Figure Asia-Pacific Sickle Cell Disease Drug Revenue Growth Rate by Type (2013-2018)
Table Asia-Pacific Sickle Cell Disease Drug Sales Volume (K Pcs) and Market Share by Region (2013-2018)
Table Asia-Pacific Sickle Cell Disease Drug Sales Share by Region (2013-2018)
Figure Sales Market Share of Sickle Cell Disease Drug by Region (2013-2018)
Figure Asia-Pacific Sickle Cell Disease Drug Sales Market Share by Region in 2017
Table Asia-Pacific Sickle Cell Disease Drug Revenue (Million USD) and Market Share by Region (2013-2018)
Table Asia-Pacific Sickle Cell Disease Drug Revenue Share (%) by Region (2013-2018)
Figure Revenue Market Share of Sickle Cell Disease Drug by Region (2013-2018)
Figure Asia-Pacific Sickle Cell Disease Drug Revenue Market Share by Region in 2017
Table Asia-Pacific Sickle Cell Disease Drug Sales Volume (K Pcs) and Market Share by Application (2013-2018)
Table Asia-Pacific Sickle Cell Disease Drug Sales Share (%) by Application (2013-2018)
Figure Asia-Pacific Sickle Cell Disease Drug Sales Market Share by Application (2013-2018)
Figure Asia-Pacific Sickle Cell Disease Drug Sales Market Share by Application (2013-2018)
Figure China Sickle Cell Disease Drug Sales (K Pcs) and Growth Rate (2013-2018)
Figure China Sickle Cell Disease Drug Revenue (Million USD) and Growth Rate (2013-2018)
Figure China Sickle Cell Disease Drug Sales Price (USD/Pcs) Trend (2013-2018)
Table China Sickle Cell Disease Drug Sales Volume (K Pcs) by Type (2013-2018)
Table China Sickle Cell Disease Drug Sales Volume Market Share by Type (2013-2018)
Figure China Sickle Cell Disease Drug Sales Volume Market Share by Type in 2017
Table China Sickle Cell Disease Drug Sales Volume (K Pcs) by Applications (2013-2018)
Table China Sickle Cell Disease Drug Sales Volume Market Share by Application (2013-2018)
Figure China Sickle Cell Disease Drug Sales Volume Market Share by Application in 2017
Figure Japan Sickle Cell Disease Drug Sales (K Pcs) and Growth Rate (2013-2018)
Figure Japan Sickle Cell Disease Drug Revenue (Million USD) and Growth Rate (2013-2018)
Figure Japan Sickle Cell Disease Drug Sales Price (USD/Pcs) Trend (2013-2018)
Table Japan Sickle Cell Disease Drug Sales Volume (K Pcs) by Type (2013-2018)
Table Japan Sickle Cell Disease Drug Sales Volume Market Share by Type (2013-2018)
Figure Japan Sickle Cell Disease Drug Sales Volume Market Share by Type in 2017
Table Japan Sickle Cell Disease Drug Sales Volume (K Pcs) by Applications (2013-2018)
Table Japan Sickle Cell Disease Drug Sales Volume Market Share by Application (2013-2018)
Figure Japan Sickle Cell Disease Drug Sales Volume Market Share by Application in 2017
Figure South Korea Sickle Cell Disease Drug Sales (K Pcs) and Growth Rate (2013-2018)
Figure South Korea Sickle Cell Disease Drug Revenue (Million USD) and Growth Rate (2013-2018)
Figure South Korea Sickle Cell Disease Drug Sales Price (USD/Pcs) Trend (2013-2018)
Table South Korea Sickle Cell Disease Drug Sales Volume (K Pcs) by Type (2013-2018)
Table South Korea Sickle Cell Disease Drug Sales Volume Market Share by Type (2013-2018)
Figure South Korea Sickle Cell Disease Drug Sales Volume Market Share by Type in 2017
Table South Korea Sickle Cell Disease Drug Sales Volume (K Pcs) by Applications (2013-2018)
Table South Korea Sickle Cell Disease Drug Sales Volume Market Share by Application (2013-2018)
Figure South Korea Sickle Cell Disease Drug Sales Volume Market Share by Application in 2017
Figure Taiwan Sickle Cell Disease Drug Sales (K Pcs) and Growth Rate (2013-2018)
Figure Taiwan Sickle Cell Disease Drug Revenue (Million USD) and Growth Rate (2013-2018)
Figure Taiwan Sickle Cell Disease Drug Sales Price (USD/Pcs) Trend (2013-2018)
Table Taiwan Sickle Cell Disease Drug Sales Volume (K Pcs) by Type (2013-2018)
Table Taiwan Sickle Cell Disease Drug Sales Volume Market Share by Type (2013-2018)
Figure Taiwan Sickle Cell Disease Drug Sales Volume Market Share by Type in 2017
Table Taiwan Sickle Cell Disease Drug Sales Volume (K Pcs) by Applications (2013-2018)
Table Taiwan Sickle Cell Disease Drug Sales Volume Market Share by Application (2013-2018)
Figure Taiwan Sickle Cell Disease Drug Sales Volume Market Share by Application in 2017
Figure India Sickle Cell Disease Drug Sales (K Pcs) and Growth Rate (2013-2018)
Figure India Sickle Cell Disease Drug Revenue (Million USD) and Growth Rate (2013-2018)
Figure India Sickle Cell Disease Drug Sales Price (USD/Pcs) Trend (2013-2018)
Table India Sickle Cell Disease Drug Sales Volume (K Pcs) by Type (2013-2018)
Table India Sickle Cell Disease Drug Sales Volume Market Share by Type (2013-2018)
Figure India Sickle Cell Disease Drug Sales Volume Market Share by Type in 2017
Table India Sickle Cell Disease Drug Sales Volume (K Pcs) by Application (2013-2018)
Table India Sickle Cell Disease Drug Sales Volume Market Share by Application (2013-2018)
Figure India Sickle Cell Disease Drug Sales Volume Market Share by Application in 2017
Figure Southeast Asia Sickle Cell Disease Drug Sales (K Pcs) and Growth Rate (2013-2018)
Figure Southeast Asia Sickle Cell Disease Drug Revenue (Million USD) and Growth Rate (2013-2018)
Figure Southeast Asia Sickle Cell Disease Drug Sales Price (USD/Pcs) Trend (2013-2018)
Table Southeast Asia Sickle Cell Disease Drug Sales Volume (K Pcs) by Type (2013-2018)
Table Southeast Asia Sickle Cell Disease Drug Sales Volume Market Share by Type (2013-2018)
Figure Southeast Asia Sickle Cell Disease Drug Sales Volume Market Share by Type in 2017
Table Southeast Asia Sickle Cell Disease Drug Sales Volume (K Pcs) by Applications (2013-2018)
Table Southeast Asia Sickle Cell Disease Drug Sales Volume Market Share by Application (2013-2018)
Figure Southeast Asia Sickle Cell Disease Drug Sales Volume Market Share by Application in 2017
Figure Australia Sickle Cell Disease Drug Sales (K Pcs) and Growth Rate (2013-2018)
Figure Australia Sickle Cell Disease Drug Revenue (Million USD) and Growth Rate (2013-2018)
Figure Australia Sickle Cell Disease Drug Sales Price (USD/Pcs) Trend (2013-2018)
Table Australia Sickle Cell Disease Drug Sales Volume (K Pcs) by Type (2013-2018)
Table Australia Sickle Cell Disease Drug Sales Volume Market Share by Type (2013-2018)
Figure Australia Sickle Cell Disease Drug Sales Volume Market Share by Type in 2017
Table Australia Sickle Cell Disease Drug Sales Volume (K Pcs) by Applications (2013-2018)
Table Australia Sickle Cell Disease Drug Sales Volume Market Share by Application (2013-2018)
Figure Australia Sickle Cell Disease Drug Sales Volume Market Share by Application in 2017
Table Acceleron Pharma Inc Sickle Cell Disease Drug Basic Information List
Table Acceleron Pharma Inc Sickle Cell Disease Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Acceleron Pharma Inc Sickle Cell Disease Drug Sales (K Pcs) and Growth Rate (2013-2018)
Figure Acceleron Pharma Inc Sickle Cell Disease Drug Sales Market Share in Asia-Pacific (2013-2018)
Figure Acceleron Pharma Inc Sickle Cell Disease Drug Revenue Market Share in Asia-Pacific (2013-2018)
Table Addmedica SAS Sickle Cell Disease Drug Basic Information List
Table Addmedica SAS Sickle Cell Disease Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Addmedica SAS Sickle Cell Disease Drug Sales (K Pcs) and Growth Rate (2013-2018)
Figure Addmedica SAS Sickle Cell Disease Drug Sales Market Share in Asia-Pacific (2013-2018)
Figure Addmedica SAS Sickle Cell Disease Drug Revenue Market Share in Asia-Pacific (2013-2018)
Table Angiocrine Bioscience Inc Sickle Cell Disease Drug Basic Information List
Table Angiocrine Bioscience Inc Sickle Cell Disease Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Angiocrine Bioscience Inc Sickle Cell Disease Drug Sales (K Pcs) and Growth Rate (2013-2018)
Figure Angiocrine Bioscience Inc Sickle Cell Disease Drug Sales Market Share in Asia-Pacific (2013-2018)
Figure Angiocrine Bioscience Inc Sickle Cell Disease Drug Revenue Market Share in Asia-Pacific (2013-2018)
Table Annexin Pharmaceuticals AB Sickle Cell Disease Drug Basic Information List
Table Annexin Pharmaceuticals AB Sickle Cell Disease Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Annexin Pharmaceuticals AB Sickle Cell Disease Drug Sales (K Pcs) and Growth Rate (2013-2018)
Figure Annexin Pharmaceuticals AB Sickle Cell Disease Drug Sales Market Share in Asia-Pacific (2013-2018)
Figure Annexin Pharmaceuticals AB Sickle Cell Disease Drug Revenue Market Share in Asia-Pacific (2013-2018)
Table ArQule Inc Sickle Cell Disease Drug Basic Information List
Table ArQule Inc Sickle Cell Disease Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure ArQule Inc Sickle Cell Disease Drug Sales (K Pcs) and Growth Rate (2013-2018)
Figure ArQule Inc Sickle Cell Disease Drug Sales Market Share in Asia-Pacific (2013-2018)
Figure ArQule Inc Sickle Cell Disease Drug Revenue Market Share in Asia-Pacific (2013-2018)
Table Bio Products Laboratory Ltd Sickle Cell Disease Drug Basic Information List
Table Bio Products Laboratory Ltd Sickle Cell Disease Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Bio Products Laboratory Ltd Sickle Cell Disease Drug Sales (K Pcs) and Growth Rate (2013-2018)
Figure Bio Products Laboratory Ltd Sickle Cell Disease Drug Sales Market Share in Asia-Pacific (2013-2018)
Figure Bio Products Laboratory Ltd Sickle Cell Disease Drug Revenue Market Share in Asia-Pacific (2013-2018)
Table Bioverativ Inc Sickle Cell Disease Drug Basic Information List
Table Bioverativ Inc Sickle Cell Disease Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Bioverativ Inc Sickle Cell Disease Drug Sales (K Pcs) and Growth Rate (2013-2018)
Figure Bioverativ Inc Sickle Cell Disease Drug Sales Market Share in Asia-Pacific (2013-2018)
Figure Bioverativ Inc Sickle Cell Disease Drug Revenue Market Share in Asia-Pacific (2013-2018)
Table bluebird bio Inc Sickle Cell Disease Drug Basic Information List
Table bluebird bio Inc Sickle Cell Disease Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure bluebird bio Inc Sickle Cell Disease Drug Sales (K Pcs) and Growth Rate (2013-2018)
Figure bluebird bio Inc Sickle Cell Disease Drug Sales Market Share in Asia-Pacific (2013-2018)
Figure bluebird bio Inc Sickle Cell Disease Drug Revenue Market Share in Asia-Pacific (2013-2018)
Table Bristol-Myers Squibb Co Sickle Cell Disease Drug Basic Information List
Table Bristol-Myers Squibb Co Sickle Cell Disease Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Bristol-Myers Squibb Co Sickle Cell Disease Drug Sales (K Pcs) and Growth Rate (2013-2018)
Figure Bristol-Myers Squibb Co Sickle Cell Disease Drug Sales Market Share in Asia-Pacific (2013-2018)
Figure Bristol-Myers Squibb Co Sickle Cell Disease Drug Revenue Market Share in Asia-Pacific (2013-2018)
Table Calimmune Inc Sickle Cell Disease Drug Basic Information List
Table Calimmune Inc Sickle Cell Disease Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Calimmune Inc Sickle Cell Disease Drug Sales (K Pcs) and Growth Rate (2013-2018)
Figure Calimmune Inc Sickle Cell Disease Drug Sales Market Share in Asia-Pacific (2013-2018)
Figure Calimmune Inc Sickle Cell Disease Drug Revenue Market Share in Asia-Pacific (2013-2018)
Table CRISPR Therapeutics Sickle Cell Disease Drug Basic Information List
Table CSL Ltd Sickle Cell Disease Drug Basic Information List
Table Daiichi Sankyo Co Ltd Sickle Cell Disease Drug Basic Information List
Table Editas Medicine Inc Sickle Cell Disease Drug Basic Information List
Table Errant Gene Therapeutics LLC Sickle Cell Disease Drug Basic Information List
Table Gamida Cell Ltd Sickle Cell Disease Drug Basic Information List
Table Genethon SA Sickle Cell Disease Drug Basic Information List
Table Gilead Sciences Inc Sickle Cell Disease Drug Basic Information List
Table Global Blood Therapeutics Inc Sickle Cell Disease Drug Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price (USD/Pcs) Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Sickle Cell Disease Drug
Figure Manufacturing Process Analysis of Sickle Cell Disease Drug
Figure Sickle Cell Disease Drug Industrial Chain Analysis
Table Raw Materials Sources of Sickle Cell Disease Drug Major Manufacturers in 2017
Table Major Buyers of Sickle Cell Disease Drug
Table Distributors/Traders List
Figure Asia-Pacific Sickle Cell Disease Drug Sales Volume (K Pcs) and Growth Rate Forecast (2018-2025)
Figure Asia-Pacific Sickle Cell Disease Drug Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure Asia-Pacific Sickle Cell Disease Drug Price (USD/Pcs) and Trend Forecast (2018-2025)
Table Asia-Pacific Sickle Cell Disease Drug Sales Volume (K Pcs) Forecast by Region (2018-2025)
Figure Asia-Pacific Sickle Cell Disease Drug Sales Volume Market Share Forecast by Region (2018-2025)
Figure Asia-Pacific Sickle Cell Disease Drug Sales Volume Market Share Forecast by Region in 2025
Table Asia-Pacific Sickle Cell Disease Drug Revenue (Million USD) Forecast by Region (2018-2025)
Figure Asia-Pacific Sickle Cell Disease Drug Revenue Market Share Forecast by Region (2018-2025)
Figure Asia-Pacific Sickle Cell Disease Drug Revenue Market Share Forecast by Region in 2025
Figure China Sickle Cell Disease Drug Sales (K Pcs) and Growth Rate Forecast (2018-2025)
Figure China Sickle Cell Disease Drug Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure Japan Sickle Cell Disease Drug Sales (K Pcs) and Growth Rate Forecast (2018-2025)
Figure Japan Sickle Cell Disease Drug Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure South Korea Sickle Cell Disease Drug Sales (K Pcs) and Growth Rate Forecast (2018-2025)
Figure South Korea Sickle Cell Disease Drug Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure Taiwan Sickle Cell Disease Drug Sales (K Pcs) and Growth Rate Forecast (2018-2025)
Figure Taiwan Sickle Cell Disease Drug Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure India Sickle Cell Disease Drug Sales (K Pcs) and Growth Rate Forecast (2018-2025)
Figure India Sickle Cell Disease Drug Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure Southeast Asia Sickle Cell Disease Drug Sales (K Pcs) and Growth Rate Forecast (2018-2025)
Figure Southeast Asia Sickle Cell Disease Drug Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure Australia Sickle Cell Disease Drug Sales (K Pcs) and Growth Rate Forecast (2018-2025)
Figure Australia Sickle Cell Disease Drug Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Table Asia-Pacific Sickle Cell Disease Drug Sales (K Pcs) Forecast by Type (2018-2025)
Figure Asia-Pacific Sickle Cell Disease Drug Sales Market Share Forecast by Type (2018-2025)
Table Asia-Pacific Sickle Cell Disease Drug Revenue (Million USD) Forecast by Type (2018-2025)
Figure Asia-Pacific Sickle Cell Disease Drug Revenue Market Share Forecast by Type (2018-2025)
Table Asia-Pacific Sickle Cell Disease Drug Price (USD/Pcs) Forecast by Type (2018-2025)
Table Asia-Pacific Sickle Cell Disease Drug Sales (K Pcs) Forecast by Application (2018-2025)
Figure Asia-Pacific Sickle Cell Disease Drug Sales Market Share Forecast by Application (2018-2025)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

More Publications

Need Help?

Ask a Question

Market Reports

All Categories